ALPHA TRIBE

Dr. Lal Path Labs Ltd.Important, 09-12-2025: Updates

09-12-2025 | 03:47 pm

Dr. Lal PathLabs declared financial results: Q revenue at 730.6 Cr, profit 150.6 Cr. H1 revenue reached 1,400.4 Cr, profit 283.0 Cr. The board approved an INR 7 interim dividend and a 1:1 bonus share issue, pending shareholder approval. Operational changes included the liquidation of Suburban Diagnostics.

No comments yet. Be the first to comment!

All announcements from Dr. Lal Path Labs Ltd.